IDIBELL on the media
Manel Esteller bestowed with the World Health Summit Award
The IDIBELL researcher receives in Berlin the World Health Summit and Pfizer Award for Innovation in Biomedical Research Manel Esteller Profile
The pathological complete response predicts a better prognosis in advanced rectal cancer
Studies review Referència de l’article
The regulation of cellular oxidation may play a key role in controlling liver cancer
Article reference
Researchers find a biomarker that predicts a good response to a new drug against breast cancer
Epigenetic inactivation of BRCA1 enhances the effect of PARP inhibitors in breast tumors Paper reference:
Manel Esteller, awarded by the International Union of Toxicology
IDIBELL’s researcher has been bestowed with the Deichmann Award
El Programa de teràpia cel·lular aproparà a la pràctica clínica els resultats de la recerca
The program’s objective is coordinating the efforts of twenty-four leading research groups working in the field of the stem cell translational research. Today, nineteen of these teams are clinical research groups (eighteen of them belong to IDIBAPS – Hospital Clinic de Barcelona and one to Bellvitge Biomedical Research Institute (IDIBELL). The five remaining centers provide […]